Taste Physiology in Obese Volunteers Before and After Bariatric Surgery
- Conditions
- Obesity
- Interventions
- Dietary Supplement: QuinineDietary Supplement: GlucoseDietary Supplement: PlaceboDietary Supplement: Monosodium glutamate
- Registration Number
- NCT02902198
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Brief Summary
The objective is to investigate neuro-anatomical correlates of gastrointestinal taste stimulation by means of functional MRI before and after bariatric surgery. Intragastric administration of glucose, monosodium glutamate, chloroquine and placebo is followed by functional brain MRI in obese humans before and 3 months after surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 16
- morbidly obese patients (BMI min 35kg/m2) scheduled for bariatric surgery
- right handed
- cardiovascular disease
- neurologic/psychiatric disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Quinine preoperative Quinine Single intragastric instillation of 200ml tap water with 17mg quinine via nasogastric tube Quinine postoperative Quinine Single intragastric instillation of 200ml tap water with 17mg quinine via nasogastric tube Glucose preoperative Glucose Single intragastric instillation of 200ml tap water with 25g glucose via nasogastric tube Placebo preoperative Placebo Single intragastric instillation of 200ml tap water via nasogastric tube Glucose postoperative Glucose Single intragastric instillation of 200ml tap water with 25g glucose via nasogastric tube Placebo postoperative Placebo Single intragastric instillation of 200ml tap water via nasogastric tube Monosodium glutamate preoperative Monosodium glutamate Single intragastric instillation of 200ml tap water with 1g monosodium glutamate via nasogastric tube Monosodium glutamate postoperative Monosodium glutamate Single intragastric instillation of 200ml tap water with 1g monosodium glutamate via nasogastric tube
- Primary Outcome Measures
Name Time Method Effect of tastants on cerebral blood flow measured by functional brain MRI changes from baseline to one hour after treatment
- Secondary Outcome Measures
Name Time Method Effect of tastants plasma glucagon-like peptide (GLP-1) concentrations changes from baseline to one hour after treatment Effect of tastants plasma ghrelin concentrations changes from baseline to one hour after treatment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Hopital Basel
🇨ðŸ‡Basel, Switzerland